Form 4: Elanco Animal Health Executive Grace McArdle Reports Stock Disposal

Grace McArdle, EVP of Manufacturing and Quality at Elanco Animal Health, reports the disposal of 3,430 shares of common stock to cover tax obligations.

Summary

• Grace McArdle, an Executive Vice President at Elanco Animal Health Inc, filed a Form 4 with the SEC on March 4, 2025.
• The form reports a transaction that occurred on March 1, 2025, where Ms. McArdle disposed of 3,430 shares of Elanco common stock.
• The disposal was related to tax obligations, with the shares being sold at a price of $11.17 per share.
• Following the transaction, Ms. McArdle beneficially owns 52,211 shares of Elanco common stock.

Sentiment

Score: 5

Explanation: This is a neutral filing related to a routine stock transaction for tax purposes. It doesn't indicate any significant positive or negative sentiment.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates a stock disposal by an executive, which is a common occurrence for covering tax obligations related to stock-based compensation.

Stakeholder Impact

• The disposal of shares by an executive could have a minor impact on shareholder sentiment, but is unlikely to be significant given the routine nature of the transaction.

Key Dates